Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
NCT01187017Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 2010
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, cyclophosphamide in aplastic anemia, sponsored by National Heart, Lung, and Blood Institute. Started Aug 2010; status: completed.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01187017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187017.